Prognostic Value of F-18-FDG PET/CT in a Large Cohort of Patients with Advanced Metastatic Neuroendocrine Neoplasms Treated with Peptide Receptor Radionuclide Therapy

Jingjing Zhang*, Qingxing Liu, Aviral Singh, Christiane Schuchardt, Harshad R. Kulkarni, Richard P. Baum

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1560-1569
Number of pages10
JournalJournal of Nuclear Medicine
Volume61
Issue number11
DOIs
Publication statusPublished - 1 Nov 2020

Keywords

  • peptide receptor radionuclide therapy
  • F-18-FDG
  • neuroendocrine neoplasms
  • Lu-177
  • Y-90
  • prognostic factor
  • EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY
  • GA-68-DOTATATE PET/CT
  • FOLLOW-UP
  • TUMORS
  • THERANOSTICS
  • MANAGEMENT
  • PREDICTS
  • SURVIVAL
  • MIDGUT
  • PRRT

Cite this